{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:16:01Z","timestamp":1794582961917,"version":"4.9.1"},"reference-count":305,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001641","name":"Glaucoma Research Foundation","doi-asserted-by":"publisher","award":["Glaucoma Research Foundation"],"award-info":[{"award-number":["Glaucoma Research Foundation"]}],"id":[{"id":"10.13039\/100001641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["BrightFocus Foundation"],"award-info":[{"award-number":["BrightFocus Foundation"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015112","name":"Melza M. and Frank Theodore Barr Foundation","doi-asserted-by":"crossref","award":["Melza M. and Frank Theodore Barr Foundation"],"award-info":[{"award-number":["Melza M. and Frank Theodore Barr Foundation"]}],"id":[{"id":"10.13039\/100015112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus Foundation, and the Melza M. and Frank Theodore Barr Foundation collaborated to bring together key opinion leaders and experts in the field of neurodegenerative disease for a virtual meeting titled \u201cSolving Neurodegeneration\u201d. This \u201cthink-tank\u201d style meeting focused on uncovering common mechanistic roots of neurodegenerative disease and promising targets for new treatments, catalyzed by the goal of finding new treatments for glaucoma, the world\u2019s leading cause of irreversible blindness and the common interest of the three hosting foundations. Glaucoma, which causes vision loss through degeneration of the optic nerve, likely shares early cellular and molecular events with other neurodegenerative diseases of the central nervous system. Here we discuss major areas of mechanistic overlap between neurodegenerative diseases of the central nervous system: neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions. We summarize important discussion points with emphasis on the research areas that are most innovative and promising in the treatment of neurodegeneration yet require further development. The research that is highlighted provides unique opportunities for collaboration that will lead to efforts in preventing neurodegeneration and ultimately vision loss.<\/jats:p>","DOI":"10.1186\/s13024-022-00524-0","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T10:02:33Z","timestamp":1647856953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":322,"title":["Solving neurodegeneration: common mechanisms and strategies for new treatments"],"prefix":"10.1186","volume":"17","author":[{"given":"Lauren K.","family":"Wareham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane A.","family":"Liddelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Temple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry I.","family":"Benowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Di Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna La","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Valeria","family":"Canto-Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharyn","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Bovenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-9959","authenticated-orcid":false,"given":"David J.","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"524_CR1","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","volume":"368","author":"MD Hurd","year":"2013","unstructured":"Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med. 2013;368:1326\u201334.","journal-title":"N Engl J Med"},{"key":"524_CR2","unstructured":"(WHO) WHO. Globa action plan on the public health response to dementia 2017\u20132025. 2017."},{"key":"524_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"524_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"524_CR5","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA. Kennedy ME and Hyman BT. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease. Nat Med. 2020;26:1256\u201363.","journal-title":"Nat Med"},{"key":"524_CR6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, Morrison JH, Gold G, Hof PR. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology. 2003;60:1495\u2013500.","journal-title":"Neurology"},{"key":"524_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology. 1992;42:631\u20139.","journal-title":"Neurology"},{"key":"524_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"524_CR9","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283:29615\u20139.","journal-title":"J Biol Chem"},{"key":"524_CR10","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11357-020-00252-7","volume":"42","author":"C Czak\u00f3","year":"2020","unstructured":"Czak\u00f3 C, Kov\u00e1cs T, Ungvari Z, Csiszar A, Yabluchanskiy A, Conley S, Csipo T, Lipecz A, Horv\u00e1th H, S\u00e1ndor GL, Istv\u00e1n L, Logan T. Nagy ZZ and Kov\u00e1cs I. Retinal biomarkers for Alzheimer\u2019s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis. GeroScience. 2020;42:1499\u2013525.","journal-title":"GeroScience"},{"key":"524_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.aay2720","volume":"365","author":"A Liesz","year":"2019","unstructured":"Liesz A. The vascular side of Alzheimer\u2019s disease. Science. 2019;365:223\u20134.","journal-title":"Science"},{"key":"524_CR12","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, Monsell SE, Kukull WA, Trojanowski JQ. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain. 2013;136:2697\u2013706.","journal-title":"Brain"},{"key":"524_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ana.25246","volume":"84","author":"MC Power","year":"2018","unstructured":"Power MC, Mormino E, Soldan A, James BD, Yu L, Armstrong NM, Bangen KJ, Delano-Wood L, Lamar M, Lim YY, Nudelman K, Zahodne L, Gross AL, Mungas D. Widaman KF and Schneider J. Combined neuropathological pathways account for age-related risk of dementia. Ann Neurol. 2018;84:10\u201322.","journal-title":"Ann Neurol"},{"key":"524_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exger.2016.11.004","volume":"94","author":"S Tarantini","year":"2017","unstructured":"Tarantini S, Tran CHT, Gordon GR, Ungvari Z, Csiszar A. Impaired neurovascular coupling in aging and Alzheimer\u2019s disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline. Exp Gerontol. 2017;94:52\u20138.","journal-title":"Exp Gerontol"},{"key":"524_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1161\/CIRCRESAHA.118.313400","volume":"123","author":"C Iadecola","year":"2018","unstructured":"Iadecola C, Gottesman RF. Cerebrovascular Alterations in Alzheimer Disease. Circ Res. 2018;123:406\u20138.","journal-title":"Circ Res"},{"key":"524_CR16","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J. Schrag AE and Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"key":"524_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2014.09.010","volume":"33","author":"S Mullin","year":"2015","unstructured":"Mullin S, Schapira AH. Pathogenic mechanisms of neurodegeneration in Parkinson disease. Neurol Clin. 2015;33:1\u201317.","journal-title":"Neurol Clin"},{"key":"524_CR18","doi-asserted-by":"crossref","unstructured":"Hyder R, Jensen M, H\u00f8jlund A, Kimppa L, Bailey CJ, Schaldemose JL, Kinnerup MB, \u00d8stergaard K, Shtyrov Y. Functional connectivity of spoken language processing in early-stage Parkinson\u2019s disease: an MEG study. NeuroImage Clin. 2021;32:102718.","DOI":"10.1016\/j.nicl.2021.102718"},{"key":"524_CR19","doi-asserted-by":"crossref","unstructured":"Dickson DW. Parkinson\u2019s disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med. 2012;2(8):a009258.","DOI":"10.1101\/cshperspect.a009258"},{"key":"524_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet. 2011;377:942\u201355.","journal-title":"Lancet"},{"key":"524_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130\u20133.","journal-title":"Science"},{"key":"524_CR22","unstructured":"WHO. Blindness and vision impairment prevention: Priority eye diseases: Glaucoma. 2020."},{"key":"524_CR23","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"key":"524_CR24","first-page":"1383","volume":"12","author":"RZ Levene","year":"1980","unstructured":"Levene RZ. Low tension glaucoma. Part II. Clinical characteristics and pathogenesis. Ann Ophthalmol. 1980;12:1383.","journal-title":"Ann Ophthalmol"},{"key":"524_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/0039-6257(80)90123-X","volume":"24","author":"RZ Levene","year":"1980","unstructured":"Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24:621\u201364.","journal-title":"Surv Ophthalmol"},{"key":"524_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2004.04.045","volume":"138","author":"RN Weinreb","year":"2004","unstructured":"Weinreb RN. Ocular hypertension: defining risks and clinical options. Am J Ophthalmol. 2004;138:1\u20132.","journal-title":"Am J Ophthalmol"},{"key":"524_CR27","doi-asserted-by":"crossref","unstructured":"Calkins DJ. Adaptive responses to neurodegenerative stress in glaucoma. Prog Retin Eye Res. 2021;84:100953.","DOI":"10.1016\/j.preteyeres.2021.100953"},{"key":"524_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.exer.2010.09.005","volume":"93","author":"CF Burgoyne","year":"2011","unstructured":"Burgoyne CF. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res. 2011;93:120\u201332.","journal-title":"Exp Eye Res"},{"key":"524_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.exer.2009.02.003","volume":"88","author":"IA Sigal","year":"2009","unstructured":"Sigal IA, Ethier CR. Biomechanics of the optic nerve head. Exp Eye Res. 2009;88:799\u2013807.","journal-title":"Exp Eye Res"},{"key":"524_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.exer.2017.02.006","volume":"157","author":"ER Tamm","year":"2017","unstructured":"Tamm ER, Ethier CR. Lasker IIoA and Glaucomatous Neurodegeneration P. Biological aspects of axonal damage in glaucoma: A brief review. Exp Eye Res. 2017;157:5\u201312.","journal-title":"Exp Eye Res"},{"key":"524_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.survophthal.2017.09.010","volume":"63","author":"M Lawlor","year":"2018","unstructured":"Lawlor M, Danesh-Meyer H, Levin LA, Davagnanam I, De Vita E, Plant GT. Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection. Surv Ophthalmol. 2018;63:296\u2013306.","journal-title":"Surv Ophthalmol"},{"key":"524_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fcell.2020.00452","volume":"8","author":"LK Wareham","year":"2020","unstructured":"Wareham LK, Calkins DJ. The Neurovascular Unit in Glaucomatous Neurodegeneration. Front Cell Dev Biol. 2020;8:452.","journal-title":"Front Cell Dev Biol"},{"key":"524_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.02.011","volume":"133","author":"JC Downs","year":"2015","unstructured":"Downs JC. Optic nerve head biomechanics in aging and disease. Exp Eye Res. 2015;133:19\u201329.","journal-title":"Exp Eye Res"},{"key":"524_CR34","doi-asserted-by":"crossref","unstructured":"Yang S, Plotnikov SV. Mechanosensitive Regulation of Fibrosis. Cells. 2021;10(5):994.","DOI":"10.3390\/cells10050994"},{"key":"524_CR35","doi-asserted-by":"publisher","first-page":"107900","DOI":"10.1016\/j.exer.2019.107900","volume":"191","author":"W Morozumi","year":"2020","unstructured":"Morozumi W, Inagaki S, Iwata Y, Nakamura S, Hara H, Shimazawa M. Piezo channel plays a part in retinal ganglion cell damage. Exp Eye Res. 2020;191:107900.","journal-title":"Exp Eye Res"},{"key":"524_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.18-25837","volume":"60","author":"B Fortune","year":"2019","unstructured":"Fortune B. Pulling and Tugging on the Retina: Mechanical Impact of Glaucoma Beyond the Optic Nerve Head. Invest Ophthalmol Vis Sci. 2019;60:26\u201335.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"524_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.survophthal.2017.06.007","volume":"63","author":"B Liu","year":"2018","unstructured":"Liu B, McNally S, Kilpatrick JI, Jarvis SP, O\u2019Brien CJ. Aging and ocular tissue stiffness in glaucoma. Surv Ophthalmol. 2018;63:56\u201374.","journal-title":"Surv Ophthalmol"},{"key":"524_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565\u201381.","journal-title":"Nat Rev Neurol"},{"key":"524_CR39","doi-asserted-by":"publisher","first-page":"669846","DOI":"10.3389\/fnut.2021.669846","volume":"8","author":"R Businaro","year":"2021","unstructured":"Businaro R, Vauzour D, Sarris J, Munch G, Gyengesi E, Brogelli L. and Zuzarte P. Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression. Front Nutr. 2021;8:669846.","journal-title":"Front Nutr"},{"key":"524_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1089\/ars.2020.8075","volume":"34","author":"I Marques-Aleixo","year":"2021","unstructured":"Marques-Aleixo I, Beleza J, Sampaio A, Stevanovic J, Coxito P, Goncalves I, Ascensao A, Magalhaes J. Preventive and Therapeutic Potential of Physical Exercise in Neurodegenerative Diseases. Antioxid Redox Signal. 2021;34:674\u201393.","journal-title":"Antioxid Redox Signal"},{"key":"524_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","volume":"157","author":"PA Williams","year":"2017","unstructured":"Williams PA, Marsh-Armstrong N, Howell GR. Lasker IIoA and Glaucomatous Neurodegeneration P. Neuroinflammation in glaucoma: A new opportunity. Exp Eye Res. 2017;157:20\u20137.","journal-title":"Exp Eye Res"},{"key":"524_CR42","doi-asserted-by":"crossref","unstructured":"Onyango IG, Jauregui GV, Carna M, Bennett JP Jr, Stokin GB. Neuroinflammation in Alzheimer\u2019s Disease. Biomedicines. 2021;9(5):524.","DOI":"10.3390\/biomedicines9050524"},{"key":"524_CR43","doi-asserted-by":"crossref","unstructured":"Rasheed M, Liang J, Wang C, Deng Y, Chen Z. Epigenetic Regulation of Neuroinflammation in Parkinson\u2019s Disease. Int J Mol Sci. 2021;22(9):4956.","DOI":"10.3390\/ijms22094956"},{"key":"524_CR44","doi-asserted-by":"publisher","first-page":"643254","DOI":"10.3389\/fphar.2021.643254","volume":"12","author":"JA Holbrook","year":"2021","unstructured":"Holbrook JA, Jarosz-Griffiths HH, Caseley E, Lara-Reyna S, Poulter JA, Williams-Gray CH. Peckham D and McDermott MF. Neurodegenerative Disease and the NLRP3 Inflammasome. Front Pharmacol. 2021;12:643254.","journal-title":"Front Pharmacol"},{"key":"524_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.immuni.2021.01.013","volume":"54","author":"RT Han","year":"2021","unstructured":"Han RT, Kim RD, Molofsky AV, Liddelow SA. Astrocyte-immune cell interactions in physiology and pathology. Immunity. 2021;54:211\u201324.","journal-title":"Immunity"},{"key":"524_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244\u201354.","journal-title":"Ann N Y Acad Sci"},{"key":"524_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/acel.12589","volume":"16","author":"G Pattabiraman","year":"2017","unstructured":"Pattabiraman G, Palasiewicz K, Galvin JP, Ucker DS. Aging-associated dysregulation of homeostatic immune response termination (and not initiation). Aging Cell. 2017;16:585\u201393.","journal-title":"Aging Cell"},{"key":"524_CR48","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","volume":"115","author":"LE Clarke","year":"2018","unstructured":"Clarke LE, Liddelow SA, Chakraborty C, Munch AE, Heiman M, Barres BA. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A. 2018;115:E1896\u2013905.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"524_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.celrep.2017.12.039","volume":"22","author":"MM Boisvert","year":"2018","unstructured":"Boisvert MM, Erikson GA, Shokhirev MN, Allen NJ. The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain. Cell Rep. 2018;22:269\u201385.","journal-title":"Cell Rep"},{"key":"524_CR50","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194\u2013217.","journal-title":"Cell"},{"issue":"Suppl 1","key":"524_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/1440-1681.12758","volume":"44","author":"Y Tang","year":"2017","unstructured":"Tang Y, Fung E, Xu A, Lan HY. C-reactive protein and ageing. Clin Exp Pharmacol Physiol. 2017;44(Suppl 1):9\u201314.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"524_CR52","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","volume":"9","author":"IM Rea","year":"2018","unstructured":"Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Front Immunol. 2018;9:586.","journal-title":"Front Immunol"},{"key":"524_CR53","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3389\/fimmu.2018.01056","volume":"9","author":"D Marcos-Perez","year":"2018","unstructured":"Marcos-Perez D, Sanchez-Flores M, Maseda A, Lorenzo-Lopez L, Millan-Calenti JC, Gostner JM, Fuchs D, Pasaro E, Laffon B. and Valdiglesias V. Frailty in Older Adults Is Associated With Plasma Concentrations of Inflammatory Mediators but Not With Lymphocyte Subpopulations. Front Immunol. 2018;9:1056.","journal-title":"Front Immunol"},{"key":"524_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41582-021-00483-y","volume":"17","author":"P Hasel","year":"2021","unstructured":"Hasel P, Liddelow SA. Isoform-dependent APOE secretion modulates neuroinflammation. Nat Rev Neurol. 2021;17:265\u20136.","journal-title":"Nat Rev Neurol"},{"key":"524_CR55","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015;3:136.","journal-title":"Ann Transl Med"},{"key":"524_CR56","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N Y)"},{"key":"524_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/ADR-200171","volume":"4","author":"B Sinyor","year":"2020","unstructured":"Sinyor B, Mineo J, Ochner C. Alzheimer\u2019s Disease, Inflammation, and the Role of Antioxidants. J Alzheimers Dis Rep. 2020;4:175\u201383.","journal-title":"J Alzheimers Dis Rep"},{"key":"524_CR58","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.2923","volume":"14","author":"M Prinz","year":"2011","unstructured":"Prinz M, Priller J, Sisodia SS, Ransohoff RM. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci. 2011;14:1227\u201335.","journal-title":"Nat Neurosci"},{"key":"524_CR59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","volume":"108","author":"JW Lewcock","year":"2020","unstructured":"Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C. Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer\u2019s Disease. Neuron. 2020;108:801\u201321.","journal-title":"Neuron"},{"key":"524_CR60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","volume":"342","author":"J Poirier","year":"1993","unstructured":"Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer\u2019s disease. Lancet. 1993;342:697\u20139.","journal-title":"Lancet"},{"key":"524_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-170777","volume":"61","author":"R Thangavel","year":"2018","unstructured":"Thangavel R, Bhagavan SM, Ramaswamy SB, Surpur S, Govindarajan R, Kempuraj D, Zaheer S, Raikwar S, Ahmed ME, Selvakumar GP, Iyer SS, Zaheer A. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer\u2019s Disease Brain. J Alzheimers Dis. 2018;61:553\u201360.","journal-title":"J Alzheimers Dis"},{"key":"524_CR62","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response. Neurobiol Aging. 2009;30:1350\u201360.","journal-title":"Neurobiol Aging"},{"key":"524_CR63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.brainres.2018.08.006","volume":"1698","author":"J Tulloch","year":"2018","unstructured":"Tulloch J, Leong L, Thomson Z, Chen S, Lee EG, Keene CD, Millard SP, Yu CE. Glia-specific APOE epigenetic changes in the Alzheimer\u2019s disease brain. Brain Res. 2018;1698:179\u201386.","journal-title":"Brain Res"},{"key":"524_CR64","doi-asserted-by":"publisher","first-page":"158980","DOI":"10.1016\/j.bbalip.2021.158980","volume":"1866","author":"AB Chai","year":"2021","unstructured":"Chai AB, Lam HHJ, Kockx M, Gelissen IC. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer\u2019s amyloid-beta. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866:158980.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"524_CR65","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ana.20694","volume":"59","author":"O Gureje","year":"2006","unstructured":"Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, Smith-Gamble V, Lane KA, Gao S, Hall KS, Hendrie HC, Murrell JR. APOE epsilon4 is not associated with Alzheimer\u2019s disease in elderly Nigerians. Ann Neurol. 2006;59:182\u20135.","journal-title":"Ann Neurol"},{"key":"524_CR66","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1096\/fj.201601084R","volume":"31","author":"BC Trumble","year":"2017","unstructured":"Trumble BC, Stieglitz J, Blackwell AD, Allayee H, Beheim B, Finch CE, Gurven M, Kaplan H. Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden. FASEB J. 2017;31:1508\u201315.","journal-title":"FASEB J"},{"key":"524_CR67","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.arcmed.2017.08.002","volume":"48","author":"M Xiying","year":"2017","unstructured":"Xiying M, Wenbo W, Wangyi F, Qinghuai L. Association of Apolipoprotein E Polymorphisms with Age-related Macular Degeneration Subtypes: An Updated Systematic Review and Meta-analysis. Arch Med Res. 2017;48:370\u20137.","journal-title":"Arch Med Res"},{"key":"524_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.61.8.3","volume":"61","author":"MA Margeta","year":"2020","unstructured":"Margeta MA, Letcher SM, Igo RP Jr, Cooke Bailey JN, Pasquale LR, Haines JL, Butovsky O. Wiggs JL and consortium N. Association of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE epsilon4. Invest Ophthalmol Vis Sci. 2020;61:3.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"524_CR69","doi-asserted-by":"publisher","first-page":"13568","DOI":"10.1523\/JNEUROSCI.2468-15.2015","volume":"35","author":"O Levy","year":"2015","unstructured":"Levy O, Lavalette S, Hu SJ, Housset M, Raoul W, Eandi C, Sahel JA, Sullivan PM. Guillonneau X and Sennlaub F. APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration. J Neurosci. 2015;35:13568\u201376.","journal-title":"J Neurosci"},{"key":"524_CR70","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1038\/s41467-020-17514-9","volume":"11","author":"KA Guttenplan","year":"2020","unstructured":"Guttenplan KA, Weigel MK, Adler DI, Couthouis J, Liddelow SA, Gitler AD, Barres BA. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun. 2020;11:3753.","journal-title":"Nat Commun"},{"key":"524_CR71","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","volume":"10","author":"E Caggiu","year":"2019","unstructured":"Caggiu E, Arru G, Hosseini S, Niegowska M, Sechi G, Zarbo IR, Sechi LA. Inflammation, Infectious Triggers, and Parkinson\u2019s Disease. Front Neurol. 2019;10:122.","journal-title":"Front Neurol"},{"key":"524_CR72","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"524_CR73","first-page":"1044","volume":"24","author":"W Shi","year":"2003","unstructured":"Shi W, Wang YM, Cheng NN, Chen BY, Li D. [Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs]. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24:1044\u20138.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"524_CR74","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, Kim S, Oh N, Kim NA, Lee S, Brahmachari S, Mao X, Lee JH, Kumar M, An D, Kang SU, Lee Y, Lee KC, Na DH, Kim D, Lee SH, Roschke VV, Liddelow SA, Mari Z, Barres BA, Dawson VL, Lee S, Dawson TM, Ko HS. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med. 2018;24:931\u20138.","journal-title":"Nat Med"},{"key":"524_CR75","doi-asserted-by":"publisher","first-page":"108271","DOI":"10.1016\/j.celrep.2020.108271","volume":"33","author":"JK Sterling","year":"2020","unstructured":"Sterling JK, Adetunji MO, Guttha S, Bargoud AR, Uyhazi KE, Ross AG, Dunaief JL, Cui QN. GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension. Cell Rep. 2020;33:108271.","journal-title":"Cell Rep"},{"key":"524_CR76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jnr.24256","volume":"97","author":"X Wei","year":"2019","unstructured":"Wei X, Cho KS, Thee EF, Jager MJ, Chen DF. Neuroinflammation and microglia in glaucoma: time for a paradigm shift. J Neurosci Res. 2019;97:70\u20136.","journal-title":"J Neurosci Res"},{"key":"524_CR77","doi-asserted-by":"crossref","unstructured":"Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM. Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Prog Retin Eye Res. 2020;83:100916.","DOI":"10.1016\/j.preteyeres.2020.100916"},{"key":"524_CR78","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/cne.22516","volume":"519","author":"A Bosco","year":"2011","unstructured":"Bosco A, Steele MR, Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011;519:599\u2013620.","journal-title":"J Comp Neurol"},{"key":"524_CR79","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI44646","volume":"121","author":"GR Howell","year":"2011","unstructured":"Howell GR, Macalinao DG, Sousa GL, Walden M, Soto I, Kneeland SC, Barbay JM, King BL, Marchant JK, Hibbs M, Stevens B, Barres BA, Clark AF, Libby RT, John SW. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121:1429\u201344.","journal-title":"J Clin Invest"},{"key":"524_CR80","doi-asserted-by":"publisher","first-page":"e67094","DOI":"10.1371\/journal.pone.0067094","volume":"8","author":"J Qu","year":"2013","unstructured":"Qu J, Jakobs TC. The Time Course of Gene Expression during Reactive Gliosis in the Optic Nerve. PLoS ONE. 2013;8:e67094.","journal-title":"PLoS ONE"},{"key":"524_CR81","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00441-013-1666-y","volume":"353","author":"R Seitz","year":"2013","unstructured":"Seitz R, Ohlmann A, Tamm ER. The role of Muller glia and microglia in glaucoma. Cell Tissue Res. 2013;353:339\u201345.","journal-title":"Cell Tissue Res"},{"key":"524_CR82","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nbd.2014.07.016","volume":"71","author":"GR Howell","year":"2014","unstructured":"Howell GR, MacNicoll KH, Braine CE, Soto I, Macalinao DG, Sousa GL, John SW. Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma. Neurobiol Dis. 2014;71:44\u201352.","journal-title":"Neurobiol Dis"},{"key":"524_CR83","doi-asserted-by":"crossref","unstructured":"Soto I, Howell GR. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med. 2014;4(8):a017269.","DOI":"10.1101\/cshperspect.a017269"},{"key":"524_CR84","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.117.8.1050","volume":"117","author":"AH Neufeld","year":"1999","unstructured":"Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol. 1999;117:1050\u20136.","journal-title":"Arch Ophthalmol"},{"key":"524_CR85","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/jnr.1104","volume":"64","author":"L Yuan","year":"2001","unstructured":"Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res. 2001;64:523\u201332.","journal-title":"J Neurosci Res"},{"key":"524_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fimmu.2020.00065","volume":"11","author":"S Jiang","year":"2020","unstructured":"Jiang S, Kametani M, Chen DF. Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy. Front Immunol. 2020;11:65.","journal-title":"Front Immunol"},{"key":"524_CR87","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fnagi.2018.00203","volume":"10","author":"AI Arroba","year":"2018","unstructured":"Arroba AI, Campos-Caro A, Aguilar-Diosdado M, Valverde AM. IGF-1, Inflammation and Retinal Degeneration: A Close Network. Front Aging Neurosci. 2018;10:203.","journal-title":"Front Aging Neurosci"},{"key":"524_CR88","first-page":"102","volume":"11","author":"MS Kottler","year":"1976","unstructured":"Kottler MS, Drance SM. Studies of hemorrhage on the optic disc. Can J Ophthalmol. 1976;11:102\u20135.","journal-title":"Can J Ophthalmol"},{"key":"524_CR89","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0161-6420(96)30572-1","volume":"103","author":"SW Siegner","year":"1996","unstructured":"Siegner SW, Netland PA. Optic disc hemorrhages and progression of glaucoma. Ophthalmology. 1996;103:1014\u201324.","journal-title":"Ophthalmology"},{"key":"524_CR90","doi-asserted-by":"publisher","first-page":"e544-9","DOI":"10.1111\/j.1755-3768.2011.02175.x","volume":"89","author":"H Resch","year":"2011","unstructured":"Resch H, Schmidl D, Hommer A, Rensch F, Jonas JB, Fuchsjager-Mayrl G, Garhofer G, Vass C, Schmetterer L. Correlation of optic disc morphology and ocular perfusion parameters in patients with primary open angle glaucoma. Acta Ophthalmol. 2011;89:e544-9.","journal-title":"Acta Ophthalmol"},{"key":"524_CR91","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/S0161-6420(97)30005-0","volume":"104","author":"K Sugiyama","year":"1997","unstructured":"Sugiyama K, Tomita G, Kitazawa Y, Onda E, Shinohara H, Park KH. The associations of optic disc hemorrhage with retinal nerve fiber layer defect and peripapillary atrophy in normal-tension glaucoma. Ophthalmology. 1997;104:1926\u201333.","journal-title":"Ophthalmology"},{"key":"524_CR92","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/archopht.1979.01020010136007","volume":"97","author":"R Susanna","year":"1979","unstructured":"Susanna R, Drance SM, Douglas GR. Disc hemorrhages in patients with elevated intraocular pressure. Occurrence with and without field changes. Arch Ophthalmol. 1979;97:284\u20135.","journal-title":"Arch Ophthalmol"},{"key":"524_CR93","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00417-019-04382-3","volume":"257","author":"K Nitta","year":"2019","unstructured":"Nitta K, Sugiyama K, Wajima R, Tachibana G, Yamada Y. Associations between changes in radial peripapillary capillaries and occurrence of disc hemorrhage in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257:1963\u201370.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"524_CR94","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0039-6257(89)90010-6","volume":"33","author":"SM Drance","year":"1989","unstructured":"Drance SM. Disc hemorrhages in the glaucomas. Surv Ophthalmol. 1989;33:331\u20137.","journal-title":"Surv Ophthalmol"},{"key":"524_CR95","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.exer.2010.08.016","volume":"93","author":"MB Wax","year":"2011","unstructured":"Wax MB. The case for autoimmunity in glaucoma. Exp Eye Res. 2011;93:187\u201390.","journal-title":"Exp Eye Res"},{"key":"524_CR96","doi-asserted-by":"publisher","first-page":"e57557","DOI":"10.1371\/journal.pone.0057557","volume":"8","author":"OW Gramlich","year":"2013","unstructured":"Gramlich OW, Beck S, von T Und Hohenstein-Blaul, Boehm N, Ziegler N, Vetter A, Pfeiffer JM N and Grus FH. Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PLoS ONE. 2013;8:e57557.","journal-title":"PLoS ONE"},{"key":"524_CR97","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1523\/JNEUROSCI.3200-08.2008","volume":"28","author":"MB Wax","year":"2008","unstructured":"Wax MB, Tezel G, Yang J, Peng G, Patil RV, Agarwal N, Sappington RM, Calkins DJ. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J Neurosci. 2008;28:12085\u201396.","journal-title":"J Neurosci"},{"key":"524_CR98","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/s41467-018-05681-9","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Cho KS, Vu THK, Shen CH, Kaur M, Chen G, Mathew R, McHam ML, Fazelat A, Lashkari K, Au NPB, Tse JKY, Li Y, Yu H, Yang L, Stein-Streilein J, Ma CHE, Woolf CJ, Whary MT, Jager MJ, Fox JG, Chen J, Chen DF. Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun. 2018;9:3209.","journal-title":"Nat Commun"},{"key":"524_CR99","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1523\/JNEUROSCI.1447-08.2008","volume":"28","author":"B Barrette","year":"2008","unstructured":"Barrette B, Hebert MA, Filali M, Lafortune K, Vallieres N, Gowing G, Julien JP, Lacroix S. Requirement of myeloid cells for axon regeneration. J Neurosci. 2008;28:9363\u201376.","journal-title":"J Neurosci"},{"key":"524_CR100","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1523\/JNEUROSCI.23-06-02284.2003","volume":"23","author":"Y Yin","year":"2003","unstructured":"Yin Y, Cui Q, Li Y, Irwin N, Fischer D, Harvey AR, Benowitz LI. Macrophage-derived factors stimulate optic nerve regeneration. J Neurosci. 2003;23:2284\u201393.","journal-title":"J Neurosci"},{"key":"524_CR101","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nn1701","volume":"9","author":"Y Yin","year":"2006","unstructured":"Yin Y, Henzl MT, Lorber B, Nakazawa T, Thomas TT, Jiang F, Langer R, Benowitz LI. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci. 2006;9:843\u201352.","journal-title":"Nat Neurosci"},{"key":"524_CR102","doi-asserted-by":"publisher","first-page":"19587","DOI":"10.1073\/pnas.0907085106","volume":"106","author":"Y Yin","year":"2009","unstructured":"Yin Y, Cui Q, Gilbert HY, Yang Y, Yang Z, Berlinicke C, Li Z, Zaverucha-do-Valle C, He H, Petkova V, Zack DJ, Benowitz LI. Oncomodulin links inflammation to optic nerve regeneration. Proc Natl Acad Sci U S A. 2009;106:19587\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"524_CR103","doi-asserted-by":"publisher","first-page":"15654","DOI":"10.1523\/JNEUROSCI.4340-10.2010","volume":"30","author":"T Kurimoto","year":"2010","unstructured":"Kurimoto T, Yin Y, Omura K, Gilbert HY, Kim D, Cen LP, Moko L, Kugler S, Benowitz LI. Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion. J Neurosci. 2010;30:15654\u201363.","journal-title":"J Neurosci"},{"key":"524_CR104","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"524_CR105","doi-asserted-by":"publisher","first-page":"107776","DOI":"10.1016\/j.celrep.2020.107776","volume":"31","author":"KA Guttenplan","year":"2020","unstructured":"Guttenplan KA, Stafford BK, El-Danaf RN, Adler DI, Munch AE, Weigel MK, Huberman AD, Liddelow SA. Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury. Cell Rep. 2020;31:107776.","journal-title":"Cell Rep"},{"key":"524_CR106","doi-asserted-by":"publisher","first-page":"18810","DOI":"10.1073\/pnas.2009425117","volume":"117","author":"ML Cooper","year":"2020","unstructured":"Cooper ML, Pasini S, Lambert WS, D\u2019Alessandro KB, Yao V, Risner ML, Calkins DJ. Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress. Proc Natl Acad Sci U S A. 2020;117:18810\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"524_CR107","doi-asserted-by":"crossref","first-page":"4581909","DOI":"10.1155\/2021\/4581909","volume":"2021","author":"JN Duarte","year":"2021","unstructured":"Duarte JN. Neuroinflammatory Mechanisms of Mitochondrial Dysfunction and Neurodegeneration in Glaucoma. J Ophthalmol. 2021;2021:4581909.","journal-title":"J Ophthalmol"},{"key":"524_CR108","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan DC. Mitochondrial Dynamics and Its Involvement in Disease. Annu Rev Pathol. 2020;15:235\u201359.","journal-title":"Annu Rev Pathol"},{"key":"524_CR109","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1073\/pnas.1107402108","volume":"108","author":"AS Rambold","year":"2011","unstructured":"Rambold AS, Kostelecky B, Elia N, Lippincott-Schwartz J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci U S A. 2011;108:10190\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"524_CR110","doi-asserted-by":"crossref","unstructured":"Eells JT. Mitochondrial Dysfunction in the Aging Retina. Biology (Basel). 2019;8(2):31.","DOI":"10.3390\/biology8020031"},{"key":"524_CR111","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"RS Balaban","year":"2005","unstructured":"Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120:483\u201395.","journal-title":"Cell"},{"key":"524_CR112","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M, Sanz E, Li Z, Hui J, Graham BH, Quintana A, Bellen HJ. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160:177\u201390.","journal-title":"Cell"},{"key":"524_CR113","doi-asserted-by":"crossref","unstructured":"Ralhan I, Chang CL, Lippincott-Schwartz J, Ioannou MS. Lipid droplets in the nervous system. J Cell Biol. 2021;220(7):e202102136.","DOI":"10.1083\/jcb.202102136"},{"key":"524_CR114","doi-asserted-by":"publisher","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8:e1000298.","journal-title":"PLoS Biol"},{"key":"524_CR115","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605\u20138.","journal-title":"Nature"},{"key":"524_CR116","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1086\/319522","volume":"68","author":"EM Valente","year":"2001","unstructured":"Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, Albanese A, Wood NW. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet. 2001;68:895\u2013900.","journal-title":"Am J Hum Genet"},{"key":"524_CR117","doi-asserted-by":"crossref","unstructured":"Buneeva O, Fedchenko V, Kopylov A, Medvedev A. Mitochondrial Dysfunction in Parkinson\u2019s Disease: Focus on Mitochondrial DNA. Biomedicines. 2020;8(12):591.","DOI":"10.3390\/biomedicines8120591"},{"key":"524_CR118","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Mitochondrial Dysfunction and Mitophagy in Parkinson\u2019s Disease: From Mechanism to Therapy. Trends Biochem Sci. 2021;46:329\u201343.","journal-title":"Trends Biochem Sci"},{"key":"524_CR119","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fnins.2020.00577","volume":"14","author":"DM O\u2019Hara","year":"2020","unstructured":"O\u2019Hara DM, Pawar G, Kalia SK, Kalia LV. LRRK2 and alpha-Synuclein: Distinct or Synergistic Players in Parkinson\u2019s Disease? Front Neurosci. 2020;14:577.","journal-title":"Front Neurosci"},{"key":"524_CR120","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34:11929\u201347.","journal-title":"J Neurosci"},{"key":"524_CR121","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, Vogel H, Steinberg GK, Edwards MS, Li G, Duncan JA 3rd, Cheshier SH, Shuer LM, Chang EF, Grant GA, Gephart MG, Barres BA. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron. 2016;89:37\u201353.","journal-title":"Neuron"},{"key":"524_CR122","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. 2020;15:30.","journal-title":"Mol Neurodegener"},{"key":"524_CR123","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.nbd.2019.03.021","volume":"127","author":"Q Wang","year":"2019","unstructured":"Wang Q, Tian J, Chen H, Du H, Guo L. Amyloid beta-mediated KIF5A deficiency disrupts anterograde axonal mitochondrial movement. Neurobiol Dis. 2019;127:410\u20138.","journal-title":"Neurobiol Dis"},{"key":"524_CR124","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/15548627.2017.1291114","volume":"13","author":"P Tammineni","year":"2017","unstructured":"Tammineni P, Cai Q. Defective retrograde transport impairs autophagic clearance in Alzheimer disease neurons. Autophagy. 2017;13:982\u20134.","journal-title":"Autophagy"},{"key":"524_CR125","doi-asserted-by":"publisher","first-page":"fcz035","DOI":"10.1093\/braincomms\/fcz035","volume":"1","author":"JR Tribble","year":"2019","unstructured":"Tribble JR, Vasalauskaite A, Redmond T, Young RD, Hassan S, Fautsch MP, Sengpiel F, Williams PA, Morgan JE. Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun. 2019;1:fcz035.","journal-title":"Brain Commun"},{"key":"524_CR126","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V, Smithies O, John SW. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355:756\u201360.","journal-title":"Science"},{"key":"524_CR127","doi-asserted-by":"publisher","first-page":"10515","DOI":"10.1073\/pnas.1509879112","volume":"112","author":"Y Takihara","year":"2015","unstructured":"Takihara Y, Inatani M, Eto K, Inoue T, Kreymerman A, Miyake S, Ueno S, Nagaya M, Nakanishi A, Iwao K, Takamura Y, Sakamoto H, Satoh K, Kondo M, Sakamoto T, Goldberg JL, Nabekura J, Tanihara H. In vivo imaging of axonal transport of mitochondria in the diseased and aged mammalian CNS. Proc Natl Acad Sci U S A. 2015;112:10515\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"524_CR128","doi-asserted-by":"publisher","first-page":"108815","DOI":"10.1016\/j.abb.2021.108815","volume":"701","author":"AG Hvozda Arana","year":"2021","unstructured":"Hvozda Arana AG, Lasagni Vitar RM, Reides CG, Calabr\u00f3 V, Marchini T, Lerner SF, Evelson PA, Ferreira SM. Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model. Arch Biochem Biophys. 2021;701:108815.","journal-title":"Arch Biochem Biophys"},{"key":"524_CR129","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.mito.2017.08.014","volume":"36","author":"YA Ito","year":"2017","unstructured":"Ito YA, Di Polo A. Mitochondrial dynamics, transport, and quality control: A bottleneck for retinal ganglion cell viability in optic neuropathies. Mitochondrion. 2017;36:186\u201392.","journal-title":"Mitochondrion"},{"key":"524_CR130","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3389\/fimmu.2018.01287","volume":"9","author":"G Swarup","year":"2018","unstructured":"Swarup G, Sayyad Z. Altered Functions and Interactions of Glaucoma-Associated Mutants of Optineurin. Front Immunol. 2018;9:1287.","journal-title":"Front Immunol"},{"key":"524_CR131","doi-asserted-by":"publisher","first-page":"681326","DOI":"10.3389\/fneur.2021.681326","volume":"12","author":"V Del Dotto","year":"2021","unstructured":"Del Dotto V, Carelli V. Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis. Front Neurol. 2021;12:681326.","journal-title":"Front Neurol"},{"key":"524_CR132","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/jmg.31.4.280","volume":"31","author":"RJ Oostra","year":"1994","unstructured":"Oostra RJ, Bolhuis PA, Wijburg FA, Zorn-Ende G, Bleeker-Wagemakers EM. Leber\u2019s hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome. J Med Genet. 1994;31:280\u20136.","journal-title":"J Med Genet"},{"key":"524_CR133","doi-asserted-by":"publisher","first-page":"651639","DOI":"10.3389\/fneur.2021.651639","volume":"12","author":"R Hage","year":"2021","unstructured":"Hage R, Vignal-Clermont C. Leber Hereditary Optic Neuropathy: Review of Treatment and Management. Front Neurol. 2021;12:651639.","journal-title":"Front Neurol"},{"key":"524_CR134","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1113\/jphysiol.1890.sp000321","volume":"11","author":"CS Roy","year":"1890","unstructured":"Roy CS, Sherrington CS. On the Regulation of the Blood-supply of the Brain. J Physiol. 1890;11:85\u2013158 17.","journal-title":"J Physiol"},{"key":"524_CR135","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron. 2017;96:17\u201342.","journal-title":"Neuron"},{"key":"524_CR136","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat Rev Neurosci. 2004;5:347\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"524_CR137","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nn.2946","volume":"14","author":"EA Winkler","year":"2011","unstructured":"Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci. 2011;14:1398\u2013405.","journal-title":"Nat Neurosci"},{"key":"524_CR138","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature09613","volume":"468","author":"D Attwell","year":"2010","unstructured":"Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 2010;468:232\u201343.","journal-title":"Nature"},{"key":"524_CR139","doi-asserted-by":"crossref","unstructured":"Hamilton NB, Attwell D, Hall CN. Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front Neuroenergetics. 2010;2:5.","DOI":"10.3389\/fnene.2010.00005"},{"key":"524_CR140","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fnins.2019.00521","volume":"13","author":"EM Rhea","year":"2019","unstructured":"Rhea EM, Banks WA. Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance. Front Neurosci. 2019;13:521.","journal-title":"Front Neurosci"},{"key":"524_CR141","doi-asserted-by":"publisher","first-page":"639140","DOI":"10.3389\/fnins.2021.639140","volume":"15","author":"G Natale","year":"2021","unstructured":"Natale G, Limanaqi F, Busceti CL, Mastroiacovo F, Nicoletti F, Puglisi-Allegra S, Fornai F. Glymphatic System as a Gateway to Connect Neurodegeneration From Periphery to CNS. Front Neurosci. 2021;15:639140.","journal-title":"Front Neurosci"},{"key":"524_CR142","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41\u201353.","journal-title":"Nat Rev Neurosci"},{"key":"524_CR143","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ni.3666","volume":"18","author":"B Engelhardt","year":"2017","unstructured":"Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017;18:123\u201331.","journal-title":"Nat Immunol"},{"key":"524_CR144","doi-asserted-by":"crossref","unstructured":"Wang X, Lou N, Eberhardt A, Yang Y, Kusk P, Xu Q, Forstera B, Peng S, Shi M, Ladron-de-Guevara A, Delle C, Sigurdsson B, Xavier ALR, Erturk A, Libby RT, Chen L, Thrane AS, Nedergaard M. An ocular glymphatic clearance system removes beta-amyloid from the rodent eye. Sci Transl Med. 2020;12(536):eaaw3210.","DOI":"10.1126\/scitranslmed.aaw3210"},{"key":"524_CR145","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/jnc.14273","volume":"144","author":"BR Price","year":"2018","unstructured":"Price BR, Norris CM, Sompol P, Wilcock DM. An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia. J Neurochem. 2018;144:644\u201350.","journal-title":"J Neurochem"},{"key":"524_CR146","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s13311-011-0047-z","volume":"8","author":"DA Levine","year":"2011","unstructured":"Levine DA, Langa KM. Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics. 2011;8:361\u201373.","journal-title":"Neurotherapeutics"},{"key":"524_CR147","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","volume":"11","author":"HM Snyder","year":"2015","unstructured":"Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC. Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease. Alzheimers Dement. 2015;11:710\u20137.","journal-title":"Alzheimers Dement"},{"key":"524_CR148","doi-asserted-by":"crossref","unstructured":"Robert J, Button EB, Yuen B, Gilmour M, Kang K, Bahrabadi A, Stukas S, Zhao W, Kulic I, Wellington CL. Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels. Elife. 2017;6:e29595.","DOI":"10.7554\/eLife.29595"},{"issue":"Suppl 1","key":"524_CR149","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0039-6257(99)00018-1","volume":"43","author":"SS Hayreh","year":"1999","unstructured":"Hayreh SS. The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43(Suppl 1):27\u201342.","journal-title":"Surv Ophthalmol"},{"key":"524_CR150","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1350-9462(01)00005-2","volume":"20","author":"SS Hayreh","year":"2001","unstructured":"Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20:595\u2013624.","journal-title":"Prog Retin Eye Res"},{"key":"524_CR151","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/bjo.53.11.721","volume":"53","author":"SS Hayreh","year":"1969","unstructured":"Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol. 1969;53:721\u201348.","journal-title":"Br J Ophthalmol"},{"key":"524_CR152","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bjo.54.7.461","volume":"54","author":"SS Hayreh","year":"1970","unstructured":"Hayreh SS, Revie IH, Edwards J. Vasogenic origin of visual field defects and optic nerve changes in glaucoma. Br J Ophthalmol. 1970;54:461\u201372.","journal-title":"Br J Ophthalmol"},{"key":"524_CR153","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41586-020-2589-x","volume":"585","author":"L Alarcon-Martinez","year":"2020","unstructured":"Alarcon-Martinez L, Villafranca-Baughman D, Quintero H, Kacerovsky JB, Dotigny F, Murai KK, Prat A, Drapeau P, Di Polo A. Interpericyte tunnelling nanotubes regulate neurovascular coupling. Nature. 2020;585:91\u20135.","journal-title":"Nature"},{"key":"524_CR154","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1167\/iovs.03-0587","volume":"44","author":"G Garhofer","year":"2003","unstructured":"Garhofer G, Zawinka C, Huemer KH, Schmetterer L, Dorner GT. Flicker light-induced vasodilatation in the human retina: effect of lactate and changes in mean arterial pressure. Invest Ophthalmol Vis Sci. 2003;44:5309\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"524_CR155","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1167\/iovs.04-1347","volume":"46","author":"G Garhofer","year":"2005","unstructured":"Garhofer G, Resch H, Weigert G, Lung S, Simader C, Schmetterer L. Short-term increase of intraocular pressure does not alter the response of retinal and optic nerve head blood flow to flicker stimulation. Invest Ophthalmol Vis Sci. 2005;46:1721\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"524_CR156","first-page":"1706","volume":"27","author":"CE Riva","year":"1986","unstructured":"Riva CE, Grunwald JE, Petrig BL. Autoregulation of human retinal blood flow. An investigation with laser Doppler velocimetry. Invest Ophthalmol Vis Sci. 1986;27:1706\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"524_CR157","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/BF00946937","volume":"235","author":"CE Riva","year":"1997","unstructured":"Riva CE, Hero M, Titze P, Petrig B. Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure. Graefes Arch Clin Exp Ophthalmol. 1997;235:618\u201326.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"524_CR158","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00061198-200408000-00013","volume":"13","author":"G Garhofer","year":"2004","unstructured":"Garhofer G, Zawinka C, Resch H, Huemer KH, Schmetterer L, Dorner GT. Response of retinal vessel diameters to flicker stimulation in patients with early open angle glaucoma. J Glaucoma. 2004;13:340\u20134.","journal-title":"J Glaucoma"},{"key":"524_CR159","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00417-011-1842-2","volume":"250","author":"K Gugleta","year":"2012","unstructured":"Gugleta K, Kochkorov A, Waldmann N, Polunina A, Katamay R, Flammer J, Orgul S. Dynamics of retinal vessel response to flicker light in glaucoma patients and ocular hypertensives. Graefes Arch Clin Exp Ophthalmol. 2012;250:589\u201394.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"524_CR160","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0079-6123(08)01125-4","volume":"173","author":"MR Hernandez","year":"2008","unstructured":"Hernandez MR, Miao H, Lukas T. Astrocytes in glaucomatous optic neuropathy. Prog Brain Res. 2008;173:353\u201373.","journal-title":"Prog Brain Res"},{"key":"524_CR161","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archopht.1968.00980050698002","volume":"80","author":"AL Kornzweig","year":"1968","unstructured":"Kornzweig AL, Eliasoph I, Feldstein M. Selective atrophy of the radial peripapillary capillaries in chronic glaucoma. Arch Ophthalmol. 1968;80:696\u2013702.","journal-title":"Arch Ophthalmol"},{"key":"524_CR162","doi-asserted-by":"crossref","unstructured":"Alarcon-Martinez L, Shiga Y, Villafranca-Baughman D, Belforte N, Quintero H, Di Polo A. Perciyte dysfunction and loss of inter-pericyte tunneling nanotubes promote neurovascular deficits in glaucoma (In press). Proc Natl Acad Sci U S A. 2022;119(7):e2110329119.","DOI":"10.1073\/pnas.2110329119"},{"key":"524_CR163","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","volume":"26","author":"JW Blanchard","year":"2020","unstructured":"Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, Victor MB, Bonner JM, Mathys H, Lin YT, Ko T, Bennett DA, Cam HP, Kellis M, Tsai LH. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;26:952\u201363.","journal-title":"Nat Med"},{"key":"524_CR164","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1126\/science.abb8575","volume":"370","author":"A Sierksma","year":"2020","unstructured":"Sierksma A, Escott-Price V, De Strooper B. Translating genetic risk of Alzheimer\u2019s disease into mechanistic insight and drug targets. Science. 2020;370:61\u20136.","journal-title":"Science"},{"key":"524_CR165","doi-asserted-by":"publisher","first-page":"104953","DOI":"10.1016\/j.nbd.2020.104953","volume":"142","author":"E Bellou","year":"2020","unstructured":"Bellou E, Stevenson-Hoare J, Escott-Price V. Polygenic risk and pleiotropy in neurodegenerative diseases. Neurobiol Dis. 2020;142:104953.","journal-title":"Neurobiol Dis"},{"key":"524_CR166","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s40142-019-0158-0","volume":"7","author":"L Ibanez","year":"2019","unstructured":"Ibanez L, Farias FHG, Dube U, Mihindukulasuriya KA, Harari O. Polygenic Risk Scores in Neurodegenerative Diseases: a Review. Curr Genetic Med Rep. 2019;7:22\u20139.","journal-title":"Curr Genetic Med Rep"},{"key":"524_CR167","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpsychires.2020.07.015","volume":"129","author":"LH Chen","year":"2020","unstructured":"Chen LH, Heng Mak TS, Fan Y, Yin Ho DT, Sham PC, Chu LW, Song YQ. Associations between CLU polymorphisms and memory performance: The role of serum lipids in Alzheimer\u2019s disease. J Psychiatr Res. 2020;129:281\u20138.","journal-title":"J Psychiatr Res"},{"key":"524_CR168","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997;17:263\u20134.","journal-title":"Nat Genet"},{"key":"524_CR169","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2002;9:305\u201318.","journal-title":"Neurobiol Dis"},{"key":"524_CR170","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, Jiang H, Sullivan PM, Baufeld C, Wood MW, Sutphen C, McCue L, Xiong C, Del-Aguila JL, Morris JC, Cruchaga C, Fagan AM, Miller BL, Boxer AL, Seeley WW, Butovsky O, Barres BA, Paul SM. Holtzman DM and Alzheimer\u2019s Disease Neuroimaging I. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137.","journal-title":"Nature"},{"key":"524_CR171","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, Butovsky O, Artyomov M, Ulrich JD, Holtzman DM. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657\u201374.e7.","journal-title":"Neuron"},{"key":"524_CR172","doi-asserted-by":"crossref","unstructured":"Davis AA, Inman CE, Wargel ZM, Dube U, Freeberg BM, Galluppi A, Haines JN, Dhavale DD, Miller R, Choudhury FA, Sullivan PM, Cruchaga C, Perlmutter JS, Ulrich JD, Benitez BA, Kotzbauer PT, Holtzman DM. APOE genotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med. 2020;12(529):eaay3069.","DOI":"10.1126\/scitranslmed.aay3069"},{"key":"524_CR173","doi-asserted-by":"crossref","unstructured":"Zhao N, Attrebi ON, Ren Y, Qiao W, Sonustun B, Martens YA, Meneses AD, Li F, Shue F, Zheng J, Van Ingelgom AJ, Davis MD, Kurti A, Knight JA, Linares C, Chen Y, Delenclos M, Liu CC, Fryer JD, Asmann YW, McLean PJ, Dickson DW, Ross OA, Bu G. APOE4 exacerbates alpha-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med. 2020;12(529):eaay1809.","DOI":"10.1126\/scitranslmed.aay1809"},{"key":"524_CR174","doi-asserted-by":"publisher","first-page":"111473","DOI":"10.1016\/j.mad.2021.111473","volume":"196","author":"JA Chowen","year":"2021","unstructured":"Chowen JA, Garcia-Segura LM. Role of glial cells in the generation of sex differences in neurodegenerative diseases and brain aging. Mech Ageing Dev. 2021;196:111473.","journal-title":"Mech Ageing Dev"},{"key":"524_CR175","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/cercor\/bhs222","volume":"23","author":"E Lentini","year":"2013","unstructured":"Lentini E, Kasahara M, Arver S, Savic I. Sex differences in the human brain and the impact of sex chromosomes and sex hormones. Cereb Cortex. 2013;23:2322\u201336.","journal-title":"Cereb Cortex"},{"key":"524_CR176","doi-asserted-by":"publisher","first-page":"100804","DOI":"10.1016\/j.yfrne.2019.100804","volume":"56","author":"S Giatti","year":"2020","unstructured":"Giatti S, Diviccaro S, Serafini MM, Caruso D, Garcia-Segura LM, Viviani B, Melcangi RC. Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role. Front Neuroendocrinol. 2020;56:100804.","journal-title":"Front Neuroendocrinol"},{"key":"524_CR177","doi-asserted-by":"publisher","first-page":"100850","DOI":"10.1016\/j.yfrne.2020.100850","volume":"58","author":"C Barth","year":"2020","unstructured":"Barth C, de Lange AG. Towards an understanding of women\u2019s brain aging: the immunology of pregnancy and menopause. Front Neuroendocrinol. 2020;58:100850.","journal-title":"Front Neuroendocrinol"},{"key":"524_CR178","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann A, Tian L, Henderson VW. Greicius MD and Alzheimer\u2019s Disease Neuroimaging Initiative I. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75:563\u201373.","journal-title":"Ann Neurol"},{"key":"524_CR179","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/STROKEAHA.107.493262","volume":"39","author":"JW Gargano","year":"2008","unstructured":"Gargano JW, Wehner S, Reeves M. Sex differences in acute stroke care in a statewide stroke registry. Stroke. 2008;39:24\u20139.","journal-title":"Stroke"},{"key":"524_CR180","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.psyneuen.2009.02.009","volume":"34","author":"MC Tierney","year":"2009","unstructured":"Tierney MC, Oh P, Moineddin R, Greenblatt EM, Snow WG, Fisher RH, Iazzetta J. Hyslop PS and MacLusky NJ. A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women. Psychoneuroendocrinology. 2009;34:1065\u201374.","journal-title":"Psychoneuroendocrinology"},{"key":"524_CR181","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3940(96)12760-9","volume":"212","author":"CA Singer","year":"1996","unstructured":"Singer CA, Rogers KL, Strickland TM, Dorsa DM. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett. 1996;212:13\u20136.","journal-title":"Neurosci Lett"},{"key":"524_CR182","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/(SICI)1099-1166(199809)13:9<625::AID-GPS835>3.0.CO;2-2","volume":"13","author":"SH MacGowan","year":"1998","unstructured":"MacGowan SH, Wilcock GK, Scott M. Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 1998;13:625\u201330.","journal-title":"Int J Geriatr Psychiatry"},{"key":"524_CR183","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/glia.20404","volume":"54","author":"LM Garcia-Segura","year":"2006","unstructured":"Garcia-Segura LM, Melcangi RC. Steroids and glial cell function. Glia. 2006;54:485\u201398.","journal-title":"Glia"},{"key":"524_CR184","doi-asserted-by":"publisher","first-page":"011509","DOI":"10.1063\/5.0035610","volume":"5","author":"CM Weber","year":"2021","unstructured":"Weber CM, Clyne AM. Sex differences in the blood-brain barrier and neurodegenerative diseases. APL Bioeng. 2021;5:011509.","journal-title":"APL Bioeng"},{"key":"524_CR185","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2018.12.030","volume":"1710","author":"LS Robison","year":"2019","unstructured":"Robison LS, Gannon OJ, Salinero AE, Zuloaga KL. Contributions of sex to cerebrovascular function and pathology. Brain Res. 2019;1710:43\u201360.","journal-title":"Brain Res"},{"key":"524_CR186","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/08820538.2015.1114845","volume":"31","author":"SS Dewundara","year":"2016","unstructured":"Dewundara SS, Wiggs JL, Sullivan DA, Pasquale LR. Is Estrogen a Therapeutic Target for Glaucoma? Semin Ophthalmol. 2016;31:140\u20136.","journal-title":"Semin Ophthalmol"},{"key":"524_CR187","doi-asserted-by":"crossref","unstructured":"Fotesko K, Thomsen BSV, Kolko M, Vohra R. Girl power in glaucoma: the role of estrogen in primary open angle glaucoma. Cell Mol Neurobiol. 2020;42(1):41-57.","DOI":"10.1007\/s10571-020-00965-5"},{"key":"524_CR188","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1042\/BIO20200063","volume":"42","author":"A Qassim","year":"2020","unstructured":"Qassim A, Siggs OM. Predicting the genetic risk of glaucoma. The Biochemist. 2020;42:26\u201330.","journal-title":"The Biochemist"},{"key":"524_CR189","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41433-019-0632-7","volume":"34","author":"H Choquet","year":"2020","unstructured":"Choquet H, Wiggs JL, Khawaja AP. Clinical implications of recent advances in primary open-angle glaucoma genetics. Eye (Lond). 2020;34:29\u201339.","journal-title":"Eye (Lond)"},{"key":"524_CR190","doi-asserted-by":"crossref","unstructured":"Rhee J, Shih KC. Use of gene therapy in retinal ganglion cell neuroprotection: current concepts and future directions. Biomolecules. 2021;11(4):581.","DOI":"10.3390\/biom11040581"},{"issue":"Suppl 1","key":"524_CR191","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/vop.12858","volume":"24","author":"AM Komaromy","year":"2021","unstructured":"Komaromy AM, Koehl KL, Park SA. Looking into the future: Gene and cell therapies for glaucoma. Vet Ophthalmol. 2021;24(Suppl 1):16\u201333.","journal-title":"Vet Ophthalmol"},{"key":"524_CR192","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jamaophthalmol.2021.2440","volume":"139","author":"OM Siggs","year":"2021","unstructured":"Siggs OM, Han X, Qassim A, Souzeau E, Kuruvilla S, Marshall HN, Mullany S, Mackey DA, Hewitt AW, Gharahkhani P, MacGregor S, Craig JE. Association of Monogenic and Polygenic Risk With the Prevalence of Open-Angle Glaucoma. JAMA Ophthalmol. 2021;139:1023\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"524_CR193","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00006324-199908000-00022","volume":"76","author":"RA Harper","year":"1999","unstructured":"Harper RA, Reeves BC. Glaucoma screening: the importance of combining test data. Optom Vis Sci. 1999;76:537\u201343.","journal-title":"Optom Vis Sci"},{"key":"524_CR194","doi-asserted-by":"publisher","first-page":"100875","DOI":"10.1016\/j.preteyeres.2020.100875","volume":"80","author":"G Beykin","year":"2021","unstructured":"Beykin G, Norcia AM, Srinivasan VJ, Dubra A, Goldberg JL. Discovery and clinical translation of novel glaucoma biomarkers. Prog Retin Eye Res. 2021;80:100875.","journal-title":"Prog Retin Eye Res"},{"key":"524_CR195","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"G Biomarkers Definitions Working","year":"2001","unstructured":"Biomarkers Definitions Working G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89\u201395.","journal-title":"Clin Pharmacol Ther"},{"key":"524_CR196","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27:954\u201363.","journal-title":"Nat Med"},{"key":"524_CR197","doi-asserted-by":"publisher","first-page":"109281","DOI":"10.1016\/j.jneumeth.2021.109281","volume":"361","author":"C Barro","year":"2021","unstructured":"Barro C, Zetterberg H. The blood biomarkers puzzle - A review of protein biomarkers in neurodegenerative diseases. J Neurosci Methods. 2021;361:109281.","journal-title":"J Neurosci Methods"},{"key":"524_CR198","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-020-00612-7","volume":"12","author":"PNE Young","year":"2020","unstructured":"Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A, Venkataraman AV, Lissaman R, Jimenez D, Betts MJ, McGlinchey E, Berron D, O\u2019Connor A, Fox NC, Pereira JB, Jagust W, Carter SF, Paterson RW, Scholl M. Imaging biomarkers in neurodegeneration: current and future practices. Alzheimers Res Ther. 2020;12:49.","journal-title":"Alzheimers Res Ther"},{"key":"524_CR199","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M, Holtta M, Rosen C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15:673\u201384.","journal-title":"Lancet Neurol"},{"key":"524_CR200","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/brain\/aww015","volume":"139","author":"S Palmqvist","year":"2016","unstructured":"Palmqvist S, Mattsson N, Hansson O. and Alzheimer\u2019s Disease Neuroimaging I. Cerebrospinal fluid analysis detects cerebral amyloid-beta accumulation earlier than positron emission tomography. Brain. 2016;139:1226\u201336.","journal-title":"Brain"},{"key":"524_CR201","doi-asserted-by":"crossref","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, Allu\u00e9 JA, Sarasa L, Eichenlaub U, Bittner T, Ovod V, Verberk IMW, Toba K, Nakamura A, Bateman RJ, Blennow K, Hansson O. Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in alzheimer disease. JAMA Neurol. 2021;78(11):1375-82.","DOI":"10.1001\/jamaneurol.2021.3180"},{"key":"524_CR202","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","volume":"97","author":"M Scholl","year":"2019","unstructured":"Scholl M, Maass A, Mattsson N, Ashton NJ, Blennow K. Zetterberg H and Jagust W. Biomarkers for tau pathology. Mol Cell Neurosci. 2019;97:18\u201333.","journal-title":"Mol Cell Neurosci"},{"key":"524_CR203","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13550-020-00653-x","volume":"10","author":"MJ Pontecorvo","year":"2020","unstructured":"Pontecorvo MJ, Keene CD, Beach TG, Montine TJ, Arora AK, Devous MD, Sr., Navitsky M, Kennedy I, Joshi AD, Lu M, Serrano GE, Sue LI, Intorcia AJ, Rose SE, Wilson A, Hellstern L, Coleman N, Flitter M, Aldea P, Fleisher AS. Mintun MA and Siderowf A. Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer\u2019s disease pathology: a clinicopathological study. EJNMMI Res. 2020;10:65.","journal-title":"EJNMMI Res"},{"key":"524_CR204","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, Fatou B, Guise AJ, Cheng L, Takeda S, Muntel J, Rotunno MS, Dujardin S, Davies P, Kosik KS, Miller BL, Berretta S, Hedreen JC, Grinberg LT, Seeley WW, Hyman BT, Steen H, Steen JA. Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer\u2019s Disease. Cell. 2020;183:1699\u2013713.e13.","journal-title":"Cell"},{"key":"524_CR205","doi-asserted-by":"crossref","unstructured":"Wang Z, Becker K, Donadio V, Siedlak S, Yuan J, Rezaee M, Incensi A, Kuzkina A, Orru CD, Tatsuoka C, Liguori R, Gunzler SA, Caughey B, Jimenez-Capdeville ME, Zhu X, Doppler K, Cui L, Chen SG, Ma J, Zou WQ. Skin alpha-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol. 2020;87(1):1-11.","DOI":"10.1001\/jamaneurol.2020.3311"},{"key":"524_CR206","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/mds.28242","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H, Serrano GE, Anantharam V, Kanthasamy A, Adler CH, Beach TG, Kanthasamy AG. Blinded RT-QuIC Analysis of alpha-Synuclein Biomarker in Skin Tissue From Parkinson\u2019s Disease Patients. Mov Disord. 2020;35:2230\u20139.","journal-title":"Mov Disord"},{"key":"524_CR207","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/acn3.51158","volume":"7","author":"NC Cullen","year":"2020","unstructured":"Cullen NC, Zetterberg H, Insel PS, Olsson B, Andreasson U, Alzheimer\u2019s Disease Neuroimaging I, Blennow K. Hansson O and Mattsson-Carlgren N. Comparing progression biomarkers in clinical trials of early Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2020;7:1661\u201373.","journal-title":"Ann Clin Transl Neurol"},{"key":"524_CR208","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.25682","volume":"87","author":"D Matuskey","year":"2020","unstructured":"Matuskey D, Tinaz S, Wilcox KC, Naganawa M, Toyonaga T, Dias M, Henry S, Pittman B, Ropchan J, Nabulsi N, Suridjan I, Comley RA, Huang Y. Finnema SJ and Carson RE. Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging. Ann Neurol. 2020;87:329\u201338.","journal-title":"Ann Neurol"},{"key":"524_CR209","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/alz.12097","volume":"16","author":"AP Mecca","year":"2020","unstructured":"Mecca AP, Chen MK, O\u2019Dell RS, Naganawa M, Toyonaga T, Godek TA, Harris JE, Bartlett HH, Zhao W, Nabulsi NB, Wyk BCV, Varma P, Arnsten AFT, Huang Y, Carson RE, van Dyck CH. In vivo measurement of widespread synaptic loss in Alzheimer\u2019s disease with SV2A PET. Alzheimers Dement. 2020;16:974\u201382.","journal-title":"Alzheimers Dement"},{"key":"524_CR210","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol. 2019;76:791\u20139.","journal-title":"JAMA Neurol"},{"key":"524_CR211","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.tips.2020.09.011","volume":"41","author":"L Gaetani","year":"2020","unstructured":"Gaetani L, Paolini Paoletti F, Bellomo G, Mancini A, Simoni S, Di Filippo M, Parnetti L. CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment. Trends Pharmacol Sci. 2020;41:1023\u201337.","journal-title":"Trends Pharmacol Sci"},{"key":"524_CR212","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","volume":"16","author":"K Nordengen","year":"2019","unstructured":"Nordengen K, Kirsebom BE, Henjum K, Selnes P, Gisladottir B, Wettergreen M, Torsetnes SB, Grontvedt GR, Waterloo KK, Aarsland D, Nilsson LNG, Fladby T. Glial activation and inflammation along the Alzheimer\u2019s disease continuum. J Neuroinflammation. 2019;16:46.","journal-title":"J Neuroinflammation"},{"key":"524_CR213","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","volume":"258","author":"M Axelsson","year":"2011","unstructured":"Axelsson M, Malmestrom C, Nilsson S, Haghighi S, Rosengren L, Lycke J. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol. 2011;258:882\u20138.","journal-title":"J Neurol"},{"key":"524_CR214","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA. and et al. Optical coherence tomography. Science. 1991;254:1178\u201381.","journal-title":"Science"},{"key":"524_CR215","doi-asserted-by":"crossref","unstructured":"Yap TE, Donna P, Almonte MT, Cordeiro MF. Real-time imaging of retinal ganglion cell apoptosis. Cells. 2018;7(6):60.","DOI":"10.3390\/cells7060060"},{"key":"524_CR216","doi-asserted-by":"crossref","unstructured":"Cordeiro MF, Hill D, Patel R, Corazza P, Maddison J, Younis S. Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic. Prog Retin Eye Res. 2021;86:100976.","DOI":"10.1016\/j.preteyeres.2021.100976"},{"key":"524_CR217","doi-asserted-by":"crossref","unstructured":"Kashani AH, Asanad S, Chan JW, Singer MB, Zhang J, Sharifi M, Khansari MM, Abdolahi F, Shi Y, Biffi A, Chui H, Ringman JM. Past, present and future role of retinal imaging in neurodegenerative disease. Prog Retin Eye Res. 2021;83:100938.","DOI":"10.1016\/j.preteyeres.2020.100938"},{"key":"524_CR218","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/NEN.0b013e31820376cc","volume":"70","author":"F Leger","year":"2011","unstructured":"Leger F, Fernagut PO, Canron MH, Leoni S, Vital C, Tison F, Bezard E, Vital A. Protein aggregation in the aging retina. J Neuropathol Exp Neurol. 2011;70:63\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"524_CR219","first-page":"204-17","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage. 2011;54(Suppl 1):204-17.","journal-title":"NeuroImage"},{"key":"524_CR220","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S. alpha-synuclein in the inner retina in parkinson disease. Ann Neurol. 2014;75:964\u20136.","journal-title":"Ann Neurol"},{"key":"524_CR221","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng C, Trojanowski JQ, Lee VM. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16:199\u2013212.","journal-title":"Nat Rev Neurol"},{"key":"524_CR222","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","volume":"480","author":"Y Lu","year":"2010","unstructured":"Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, Ma D. Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography. Neurosci Lett. 2010;480:69\u201372.","journal-title":"Neurosci Lett"},{"key":"524_CR223","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1167\/iovs.13-12046","volume":"54","author":"E Marziani","year":"2013","unstructured":"Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C, Staurenghi G. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer\u2019s disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54:5953\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"524_CR224","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-141659","volume":"45","author":"CY Cheung","year":"2015","unstructured":"Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, Venketasubramanian N, Yap P, Seow D, Chen CL, Wong TY. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45:45\u201356.","journal-title":"J Alzheimers Dis"},{"key":"524_CR225","doi-asserted-by":"publisher","first-page":"e0134750","DOI":"10.1371\/journal.pone.0134750","volume":"10","author":"G Coppola","year":"2015","unstructured":"Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, Barboni P, Pierelli F. Sadun AA and Parisi V. Optical Coherence Tomography in Alzheimer\u2019s Disease: A Meta-Analysis. PLoS ONE. 2015;10:e0134750.","journal-title":"PLoS ONE"},{"key":"524_CR226","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/bjophthalmol-2017-310476","volume":"102","author":"M Bulut","year":"2018","unstructured":"Bulut M, Kurtulus F, Gozkaya O, Erol MK, Cengiz A, Akidan M, Yaman A. Evaluation of optical coherence tomography angiographic findings in Alzheimer\u2019s type dementia. Br J Ophthalmol. 2018;102:233\u20137.","journal-title":"Br J Ophthalmol"},{"key":"524_CR227","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaophthalmol.2018.3556","volume":"136","author":"BE O\u2019Bryhim","year":"2018","unstructured":"O\u2019Bryhim BE, Apte RS, Kung N, Coble D, Van Stavern GP. Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings. JAMA Ophthalmol. 2018;136:1242\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"524_CR228","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fcell.2020.00328","volume":"8","author":"A Slanzi","year":"2020","unstructured":"Slanzi A, Iannoto G, Rossi B, Zenaro E, Constantin G. In vitro Models of Neurodegenerative Diseases. Front Cell Dev Biol. 2020;8:328.","journal-title":"Front Cell Dev Biol"},{"key":"524_CR229","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jalz.2015.12.003","volume":"12","author":"S Gauthier","year":"2016","unstructured":"Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 2016;12:60\u20134.","journal-title":"Alzheimers Dement"},{"key":"524_CR230","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings JL, Morstorf T, Zhong K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6:37.","journal-title":"Alzheimers Res Ther"},{"key":"524_CR231","doi-asserted-by":"crossref","unstructured":"Spanos F, Liddelow SA. An overview of astrocyte responses in genetically induced Alzheimer\u2019s disease mouse models. Cells. 2020;9(11):2415.","DOI":"10.3390\/cells9112415"},{"key":"524_CR232","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1167\/iovs.09-3947","volume":"51","author":"RM Sappington","year":"2010","unstructured":"Sappington RM, Carlson BJ, Crish SD, Calkins DJ. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci. 2010;51:207\u201316.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"524_CR233","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.preteyeres.2019.100799","volume":"75","author":"IH Pang","year":"2020","unstructured":"Pang IH, Clark AF. Inducible rodent models of glaucoma. Prog Retin Eye Res. 2020;75:100799.","journal-title":"Prog Retin Eye Res"},{"key":"524_CR234","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1111\/aos.13983","volume":"97","author":"S Biswas","year":"2019","unstructured":"Biswas S, Wan KH. Review of rodent hypertensive glaucoma models. Acta Ophthalmol. 2019;97:e331\u201340.","journal-title":"Acta Ophthalmol"},{"key":"524_CR235","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.expneurol.2015.12.015","volume":"287","author":"LI Benowitz","year":"2017","unstructured":"Benowitz LI, He Z, Goldberg JL. Reaching the brain: Advances in optic nerve regeneration. Exp Neurol. 2017;287:365\u201373.","journal-title":"Exp Neurol"},{"key":"524_CR236","doi-asserted-by":"publisher","first-page":"100880","DOI":"10.1016\/j.preteyeres.2020.100880","volume":"81","author":"S Schnichels","year":"2021","unstructured":"Schnichels S, Paquet-Durand F, Loscher M, Tsai T, Hurst J, Joachim SC, Klettner A. Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina. Prog Retin Eye Res. 2021;81:100880.","journal-title":"Prog Retin Eye Res"},{"key":"524_CR237","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.neuron.2011.07.022","volume":"71","author":"LC Foo","year":"2011","unstructured":"Foo LC, Allen NJ, Bushong EA, Ventura PB, Chung WS, Zhou L, Cahoy JD, Daneman R, Zong H, Ellisman MH, Barres BA. Development of a method for the purification and culture of rodent astrocytes. Neuron. 2011;71:799\u2013811.","journal-title":"Neuron"},{"key":"524_CR238","doi-asserted-by":"crossref","unstructured":"Collins HY, Bohlen CJ. Isolation and culture of rodent microglia to promote a dynamic ramified morphology in serum-free medium. J Vis Exp. 2018;133:57122.","DOI":"10.3791\/57122"},{"key":"524_CR239","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1002\/cpim.70","volume":"125","author":"CJ Bohlen","year":"2019","unstructured":"Bohlen CJ, Bennett FC, Bennett ML. Isolation and Culture of Microglia. Curr Protoc Immunol. 2019;125:e70.","journal-title":"Curr Protoc Immunol"},{"key":"524_CR240","doi-asserted-by":"publisher","first-page":"E1738-46","DOI":"10.1073\/pnas.1525528113","volume":"113","author":"ML Bennett","year":"2016","unstructured":"Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, Mulinyawe SB, Bohlen CJ, Adil A, Tucker A, Weissman IL, Chang EF, Li G, Grant GA. Hayden Gephart MG and Barres BA. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016;113:E1738-46.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"524_CR241","doi-asserted-by":"crossref","unstructured":"Oca\u00f1as SR, Pham KD, Blankenship HE, Machalinski AH, Chucair-Elliott AJ, Freeman WM. Minimizing the < em > ex vivo<\/em > confounds of cell-isolation techniques on transcriptomic -profiles of purified microglia. bioRxiv. 2021:2021.07.15.452509.","DOI":"10.1101\/2021.07.15.452509"},{"key":"524_CR242","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.neuron.2020.05.014","volume":"107","author":"L Barbar","year":"2020","unstructured":"Barbar L, Jain T, Zimmer M, Kruglikov I, Sadick JS, Wang M, Kalpana K, Rose IVL, Burstein SR, Rusielewicz T, Nijsure M, Guttenplan KA, di Domenico A, Croft G, Zhang B, Nobuta H, Hebert JM. Liddelow SA and Fossati V. CD49f Is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes. Neuron. 2020;107:436\u201353. e12.","journal-title":"Neuron"},{"key":"524_CR243","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41596-018-0029-2","volume":"13","author":"J Qiu","year":"2018","unstructured":"Qiu J, Dando O, Baxter PS, Hasel P, Heron S, Simpson TI, Hardingham GE. Mixed-species RNA-seq for elucidation of non-cell-autonomous control of gene transcription. Nat Protoc. 2018;13:2176\u201399.","journal-title":"Nat Protoc"},{"key":"524_CR244","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-neuro-070918-050154","volume":"43","author":"S Velasco","year":"2020","unstructured":"Velasco S, Paulsen B, Arlotta P. 3D Brain Organoids: Studying Brain Development and Disease Outside the Embryo. Annu Rev Neurosci. 2020;43:375\u201389.","journal-title":"Annu Rev Neurosci"},{"key":"524_CR245","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-vision-121219-081855","volume":"6","author":"CM Bell","year":"2020","unstructured":"Bell CM, Zack DJ, Berlinicke CA. Human Organoids for the Study of Retinal Development and Disease. Annu Rev Vis Sci. 2020;6:91\u2013114.","journal-title":"Annu Rev Vis Sci"},{"key":"524_CR246","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1016\/j.cell.2021.07.003","volume":"184","author":"KR Bowles","year":"2021","unstructured":"Bowles KR, Silva MC, Whitney K, Bertucci T, Berlind JE, Lai JD, Garza JC, Boles NC, Mahali S, Strang KH, Marsh JA, Chen C, Pugh DA, Liu Y, Gordon RE, Goderie SK, Chowdhury R, Lotz S, Lane K, Crary JF, Haggarty SJ, Karch CM, Ichida JK, Goate AM, Temple S. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids. Cell. 2021;184:4547\u201363.e17.","journal-title":"Cell"},{"key":"524_CR247","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/ncomms5047","volume":"5","author":"X Zhong","year":"2014","unstructured":"Zhong X, Gutierrez C, Xue T, Hampton C, Vergara MN, Cao LH, Peters A, Park TS, Zambidis ET, Meyer JS, Gamm DM, Yau KW, Canto-Soler MV. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun. 2014;5:4047.","journal-title":"Nat Commun"},{"key":"524_CR248","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1242\/dev.146290","volume":"144","author":"MN Vergara","year":"2017","unstructured":"Vergara MN, Flores-Bellver M, Aparicio-Domingo S, McNally M, Wahlin KJ, Saxena MT, Mumm JS, Canto-Soler MV. Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids. Development. 2017;144:3698\u2013705.","journal-title":"Development"},{"key":"524_CR249","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13024-020-00418-z","volume":"15","author":"J Robert","year":"2020","unstructured":"Robert J, Weilinger NL, Cao L-P, Cataldi S, Button EB, Stukas S, Martin EM, Seibler P, Gilmour M, Caffrey TM, Rowe EM, Fan J, MacVicar B. Farrer MJ and Wellington CL. An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. Mol neurodegeneration. 2020;15:70\u20130.","journal-title":"Mol neurodegeneration"},{"key":"524_CR250","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nbt.4127","volume":"36","author":"AA Mansour","year":"2018","unstructured":"Mansour AA, Goncalves JT, Bloyd CW, Li H, Fernandes S, Quang D, Johnston S, Parylak SL, Jin X, Gage FH. An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol. 2018;36:432\u201341.","journal-title":"Nat Biotechnol"},{"key":"524_CR251","unstructured":"National Academies of Sciences E. Medicine, Policy, Global A, Committee on Science T, Law. Committee on Ethical L, Regulatory Issues Associated with Neural C and Organoids. The National Academies Collection: Reports funded by National Institutes of Health The Emerging Field of Human Neural Organoids, Transplants, and Chimeras: Science, Ethics, and Governance Washington (DC): National Academies Press (US). Copyright 2021 by the National Academy of Sciences. All rights reserved.; 2021."},{"key":"524_CR252","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41563-020-00804-4","volume":"20","author":"E Garreta","year":"2021","unstructured":"Garreta E, Kamm RD, Chuva de Sousa Lopes SM, Lancaster MA, Weiss R, Trepat X. Hyun I and Montserrat N. Rethinking organoid technology through bioengineering. Nat Mater. 2021;20:145\u201355.","journal-title":"Nat Mater"},{"key":"524_CR253","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","volume":"26","author":"H Zetterberg","year":"2021","unstructured":"Zetterberg H, Bendlin BB. Biomarkers for Alzheimer\u2019s disease\u2014preparing for a new era of disease-modifying therapies. Mol Psychiatry. 2021;26:296\u2013308.","journal-title":"Mol Psychiatry"},{"key":"524_CR254","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev-vision-022720-094953","volume":"6","author":"PR Williams","year":"2020","unstructured":"Williams PR, Benowitz LI, Goldberg JL, He Z. Axon Regeneration in the Mammalian Optic Nerve. Annu Rev Vis Sci. 2020;6:195\u2013213.","journal-title":"Annu Rev Vis Sci"},{"key":"524_CR255","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J. and Alzheimer Genetic Analysis G. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"524_CR256","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U. Kong A and Stefansson K. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"524_CR257","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, Norton JB, Hsu S, Harari O, Cai Y, Bertelsen S, Goate AM, Cruchaga C. Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet. 2014;23:5838\u201346.","journal-title":"Hum Mol Genet"},{"key":"524_CR258","doi-asserted-by":"publisher","first-page":"111438","DOI":"10.1016\/j.mad.2021.111438","volume":"195","author":"Q Qin","year":"2021","unstructured":"Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Y. TREM2, microglia, and Alzheimer\u2019s disease. Mech Ageing Dev. 2021;195:111438.","journal-title":"Mech Ageing Dev"},{"key":"524_CR259","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrg3461","volume":"14","author":"N Solovieff","year":"2013","unstructured":"Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14:483\u201395.","journal-title":"Nat Rev Genet"},{"key":"524_CR260","doi-asserted-by":"publisher","first-page":"e1002487","DOI":"10.1371\/journal.pmed.1002487","volume":"15","author":"I Broce","year":"2018","unstructured":"Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CH, Kouri N, Ross OA, Hoglinger GU, Muller U, Hardy J, International FTDGC, Momeni P, Hess CP, Dillon WP, Miller ZA, Bonham LW, Rabinovici GD, Rosen HJ, Schellenberg GD, Franke A, Karlsen TH, Veldink JH, Ferrari R, Yokoyama JS, Miller BL, Andreassen OA, Dale AM, Desikan RS, Sugrue LP. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLoS Med. 2018;15:e1002487.","journal-title":"PLoS Med"},{"key":"524_CR261","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci. 2020;23:311\u201322.","journal-title":"Nat Neurosci"},{"key":"524_CR262","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-021-00467-y","volume":"16","author":"E McDade","year":"2021","unstructured":"McDade E, Llibre-Guerra JJ, Holtzman DM, Morris JC, Bateman RJ. The informed road map to prevention of Alzheimer Disease: A call to arms. Mol Neurodegeneration. 2021;16:49.","journal-title":"Mol Neurodegeneration"},{"key":"524_CR263","doi-asserted-by":"publisher","first-page":"108623","DOI":"10.1016\/j.jneumeth.2020.108623","volume":"335","author":"N El Seblani","year":"2020","unstructured":"El Seblani N, Welleford AS, Quintero JE, van Horne CG, Gerhardt GA. Invited review: Utilizing peripheral nerve regenerative elements to repair damage in the CNS. J Neurosci Methods. 2020;335:108623.","journal-title":"J Neurosci Methods"},{"key":"524_CR264","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1523\/JNEUROSCI.1747-16.2016","volume":"36","author":"MA Marin","year":"2016","unstructured":"Marin MA, de Lima S, Gilbert HY, Giger RJ, Benowitz L, Rasband MN. Reassembly of Excitable Domains after CNS Axon Regeneration. J Neurosci. 2016;36:9148\u201360.","journal-title":"J Neurosci"},{"key":"524_CR265","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.neuron.2020.09.016","volume":"108","author":"J Wang","year":"2020","unstructured":"Wang J, He X, Meng H, Li Y, Dmitriev P, Tian F, Page JC, Lu QR, He Z. Robust Myelination of Regenerated Axons Induced by Combined Manipulations of GPR17 and Microglia. Neuron. 2020;108:876\u201386.e4.","journal-title":"Neuron"},{"key":"524_CR266","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.neuron.2015.03.060","volume":"86","author":"S Belin","year":"2015","unstructured":"Belin S, Nawabi H, Wang C, Tang S, Latremoliere A, Warren P, Schorle H, Uncu C, Woolf CJ, He Z, Steen JA. Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics. Neuron. 2015;86:1000\u201314.","journal-title":"Neuron"},{"key":"524_CR267","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nn.4340","volume":"19","author":"JH Lim","year":"2016","unstructured":"Lim JH, Stafford BK, Nguyen PL, Lien BV, Wang C, Zukor K, He Z, Huberman AD. Neural activity promotes long-distance, target-specific regeneration of adult retinal axons. Nat Neurosci. 2016;19:1073\u201384.","journal-title":"Nat Neurosci"},{"key":"524_CR268","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1006\/exnr.2001.7822","volume":"172","author":"D Fischer","year":"2001","unstructured":"Fischer D, Heiduschka P, Thanos S. Lens-injury-stimulated axonal regeneration throughout the optic pathway of adult rats. Exp Neurol. 2001;172:257\u201372.","journal-title":"Exp Neurol"},{"key":"524_CR269","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1523\/JNEUROSCI.20-12-04615.2000","volume":"20","author":"S Leon","year":"2000","unstructured":"Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci. 2000;20:4615\u201326.","journal-title":"J Neurosci"},{"key":"524_CR270","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1073\/pnas.1423221112","volume":"112","author":"KT Baldwin","year":"2015","unstructured":"Baldwin KT, Carbajal KS, Segal BM, Giger RJ. Neuroinflammation triggered by beta-glucan\/dectin-1 signaling enables CNS axon regeneration. Proc Natl Acad Sci U S A. 2015;112:2581\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"524_CR271","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","volume":"16","author":"JD Rothstein","year":"1996","unstructured":"Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16:675\u201386.","journal-title":"Neuron"},{"key":"524_CR272","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol. 2005;171:1001\u201312.","journal-title":"J Cell Biol"},{"key":"524_CR273","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2709-7","volume":"588","author":"J Zhang","year":"2020","unstructured":"Zhang J, Velmeshev D, Hashimoto K, Huang Y-H, Hofmann JW, Shi X, Chen J, Leidal AM, Dishart JG, Cahill MK, Kelley KW, Liddelow SA, Seeley WW, Miller BL, Walther TC, Farese RV, Taylor JP, Ullian EM, Huang B, Debnath J, Wittmann T, Kriegstein AR, Huang EJ. Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency. Nature. 2020;588:459\u201365.","journal-title":"Nature"},{"key":"524_CR274","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","volume":"590","author":"LM Sanmarco","year":"2021","unstructured":"Sanmarco LM, Wheeler MA, Guti\u00e9rrez-V\u00e1zquez C, Polonio CM, Linnerbauer M, Pinho-Ribeiro FA, Li Z, Giovannoni F, Batterman KV, Scalisi G, Zandee SEJ, Heck ES, Alsuwailm M, Rosene DL, Becher B, Chiu IM. Prat A and Quintana FJ. Gut-licensed IFN\u03b3(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes. Nature. 2021;590:473\u20139.","journal-title":"Nature"},{"key":"524_CR275","doi-asserted-by":"publisher","first-page":"10472","DOI":"10.1038\/ncomms10472","volume":"7","author":"P Venugopalan","year":"2016","unstructured":"Venugopalan P, Wang Y, Nguyen T, Huang A, Muller KJ, Goldberg JL. Transplanted neurons integrate into adult retinas and respond to light. Nat Commun. 2016;7:10472.","journal-title":"Nat Commun"},{"key":"524_CR276","doi-asserted-by":"crossref","unstructured":"Coco-Martin RM, Pastor-Idoate S, Pastor JC. Cell replacement therapy for retinal and optic nerve diseases: cell sources, clinical trials and challenges. Pharmaceutics. 2021;13(6):865.","DOI":"10.3390\/pharmaceutics13060865"},{"key":"524_CR277","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/dvdy.24672","volume":"248","author":"AM Miltner","year":"2019","unstructured":"Miltner AM, La Torre A. Retinal Ganglion Cell Replacement: Current Status and Challenges Ahead. Dev Dyn. 2019;248:118\u201328.","journal-title":"Dev Dyn"},{"key":"524_CR278","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stemcr.2020.12.001","volume":"16","author":"KY Zhang","year":"2021","unstructured":"Zhang KY, Tuffy C, Mertz JL, Quillen S, Wechsler L, Quigley HA, Zack DJ, Johnson TV. Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells. Stem Cell Reports. 2021;16:149\u201367.","journal-title":"Stem Cell Reports"},{"key":"524_CR279","doi-asserted-by":"crossref","unstructured":"Pereiro X, Miltner AM, La Torre A, Vecino E. Effects of adult muller cells and their conditioned media on the survival of stem cell-derived retinal ganglion cells. Cells. 2020;9(8):1759.","DOI":"10.3390\/cells9081759"},{"key":"524_CR280","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","volume":"104","author":"NM Tran","year":"2019","unstructured":"Tran NM, Shekhar K, Whitney IE, Jacobi A, Benhar I, Hong G, Yan W, Adiconis X, Arnold ME, Lee JM, Levin JZ, Lin D, Wang C, Lieber CM, Regev A, He Z, Sanes JR. Single-Cell Profiles of Retinal Ganglion Cells Differing in Resilience to Injury Reveal Neuroprotective Genes. Neuron. 2019;104:1039\u201355. e12.","journal-title":"Neuron"},{"key":"524_CR281","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuron.2015.02.017","volume":"85","author":"X Duan","year":"2015","unstructured":"Duan X, Qiao M, Bei F, Kim IJ, He Z, Sanes JR. Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling. Neuron. 2015;85:1244\u201356.","journal-title":"Neuron"},{"key":"524_CR282","doi-asserted-by":"publisher","first-page":"17359","DOI":"10.1038\/s41598-020-71460-6","volume":"10","author":"KB VanderWall","year":"2020","unstructured":"VanderWall KB, Lu B, Alfaro JS, Allsop AR, Carr AS, Wang S, Meyer JS. Differential susceptibility of retinal ganglion cell subtypes in acute and chronic models of injury and disease. Sci Rep. 2020;10:17359.","journal-title":"Sci Rep"},{"key":"524_CR283","doi-asserted-by":"publisher","first-page":"9802","DOI":"10.1038\/s41598-020-66092-9","volume":"10","author":"W Yan","year":"2020","unstructured":"Yan W, Peng YR, van Zyl T, Regev A, Shekhar K, Juric D, Sanes JR. Cell Atlas of The Human Fovea and Peripheral Retina. Sci Rep. 2020;10:9802.","journal-title":"Sci Rep"},{"key":"524_CR284","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.devcel.2020.04.009","volume":"53","author":"Y Lu","year":"2020","unstructured":"Lu Y, Shiau F, Yi W, Lu S, Wu Q, Pearson JD, Kallman A, Zhong S, Hoang T, Zuo Z, Zhao F, Zhang M, Tsai N, Zhuo Y, He S, Zhang J, Stein-O\u2019Brien GL, Sherman TD, Duan X, Fertig EJ, Goff LA, Zack DJ, Handa JT, Xue T, Bremner R, Blackshaw S, Wang X, Clark BS. Single-Cell Analysis of Human Retina Identifies Evolutionarily Conserved and Species-Specific Mechanisms Controlling Development. Dev Cell. 2020;53:473\u201391. e9.","journal-title":"Dev Cell"},{"key":"524_CR285","doi-asserted-by":"crossref","unstructured":"Shekhar K, Whitney IE, Butrus S, Peng Y-R, Sanes JR. Diversification of multipotential postmitotic mouse retinal ganglion cell precursors into discrete types. bioRxiv. 2021:2021.10.21.465277.","DOI":"10.1101\/2021.10.21.465277"},{"key":"524_CR286","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","volume":"103","author":"A Atri","year":"2019","unstructured":"Atri A. The Alzheimer\u2019s Disease Clinical Spectrum: Diagnosis and Management. Med Clin North Am. 2019;103:263\u201393.","journal-title":"Med Clin North Am"},{"key":"524_CR287","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","volume":"16","author":"J Cummings","year":"2021","unstructured":"Cummings J. New approaches to symptomatic treatments for Alzheimer\u2019s disease. Mol Neurodegener. 2021;16:2.","journal-title":"Mol Neurodegener"},{"key":"524_CR288","doi-asserted-by":"publisher","first-page":"n1682","DOI":"10.1136\/bmj.n1682","volume":"374","author":"S Walsh","year":"2021","unstructured":"Walsh S, Merrick R, Milne R, Brayne C. Aducanumab for Alzheimer\u2019s disease? BMJ. 2021;374:n1682.","journal-title":"BMJ"},{"key":"524_CR289","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O\u2019Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C. Nitsch RM and Sandrock A. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537:50\u20136.","journal-title":"Nature"},{"key":"524_CR290","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/d41586-021-01546-2","volume":"594","author":"A Mullard","year":"2021","unstructured":"Mullard A. Landmark Alzheimer\u2019s drug approval confounds research community. Nature. 2021;594:309\u201310.","journal-title":"Nature"},{"key":"524_CR291","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.abk0575","volume":"372","author":"JS Perlmutter","year":"2021","unstructured":"Perlmutter JS. FDA\u2019s green light, science\u2019s red light. Science. 2021;372:1371\u20131.","journal-title":"Science"},{"key":"524_CR292","doi-asserted-by":"publisher","first-page":"e14781","DOI":"10.15252\/emmm.202114781","volume":"13","author":"G Lalli","year":"2021","unstructured":"Lalli G, Schott JM, Hardy J, De Strooper B. Aducanumab: a new phase in therapeutic development for Alzheimer\u2019s disease? EMBO Mol Med. 2021;13:e14781.","journal-title":"EMBO Mol Med"},{"key":"524_CR293","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-021-00452-5","volume":"16","author":"M Seto","year":"2021","unstructured":"Seto M, Weiner RL, Dumitrescu L, Hohman TJ. Protective genes and pathways in Alzheimer\u2019s disease: moving towards precision interventions. Mol Neurodegeneration. 2021;16:29.","journal-title":"Mol Neurodegeneration"},{"key":"524_CR294","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-019-0479-y","volume":"11","author":"TJ Montine","year":"2019","unstructured":"Montine TJ, Cholerton BA, Corrada MM, Edland SD, Flanagan ME, Hemmy LS, Kawas CH, White LR. Concepts for brain aging: resistance, resilience, reserve, and compensation. Alzheimers Res Ther. 2019;11:22.","journal-title":"Alzheimers Res Ther"},{"key":"524_CR295","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1212\/WNL.0000000000003397","volume":"87","author":"TJ Hohman","year":"2016","unstructured":"Hohman TJ, McLaren DG, Mormino EC, Gifford KA, Libon DJ, Jefferson AL. Asymptomatic Alzheimer disease: Defining resilience. Neurology. 2016;87:2443\u201350.","journal-title":"Neurology"},{"key":"524_CR296","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/156720511795745348","volume":"8","author":"I Driscoll","year":"2011","unstructured":"Driscoll I, Troncoso J. Asymptomatic Alzheimer\u2019s disease: a prodrome or a state of resilience? Curr Alzheimer Res. 2011;8:330\u20135.","journal-title":"Curr Alzheimer Res"},{"key":"524_CR297","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, J\u00f6nsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U. Watts RJ and Stefansson K. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature. 2012;488:96\u20139.","journal-title":"Nature"},{"key":"524_CR298","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ana.24969","volume":"82","author":"H Martiskainen","year":"2017","unstructured":"Martiskainen H, Herukka S-K, Stan\u010d\u00e1kov\u00e1 A, Paananen J, Soininen H, Kuusisto J, Laakso M, Hiltunen M. Decreased plasma \u03b2-amyloid in the Alzheimer\u2019s disease APP A673T variant carriers. Ann Neurol. 2017;82:128\u201332.","journal-title":"Ann Neurol"},{"key":"524_CR299","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, Saez-Torres KL, Amarnani D, Schultz AP, Sperling RA, Leyton-Cifuentes D, Chen K, Baena A, Aguillon D, Rios-Romenets S, Giraldo M, Guzm\u00e1n-V\u00e9lez E, Norton DJ, Pardilla-Delgado E, Artola A, Sanchez JS, Acosta-Uribe J, Lalli M, Kosik KS, Huentelman MJ, Zetterberg H, Blennow K, Reiman RA, Luo J, Chen Y, Thiyyagura P, Su Y, Jun GR, Naymik M, Gai X, Bootwalla M, Ji J, Shen L, Miller JB, Kim LA, Tariot PN, Johnson KA, Reiman EM, Quiroz YT. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25:1680\u20133.","journal-title":"Nat Med"},{"key":"524_CR300","doi-asserted-by":"publisher","first-page":"eabc9375","DOI":"10.1126\/scitranslmed.abc9375","volume":"13","author":"CC Liu","year":"2021","unstructured":"Liu CC, Murray ME, Li X, Zhao N, Wang N, Heckman MG, Shue F, Martens Y, Li Y, Raulin AC, Rosenberg CL, Doss SV, Zhao J, Wren MC, Jia L, Ren Y, Ikezu TC, Lu W, Fu Y, Caulfield T, Trottier ZA, Knight J, Chen Y, Linares C, Wang X, Kurti A, Asmann YW, Wszolek ZK, Smith GE, Vemuri P, Kantarci K, Knopman DS, Lowe VJ, Jack CR Jr, Parisi JE, Ferman TJ, Boeve BF, Graff-Radford NR, Petersen RC, Younkin SG, Fryer JD, Wang H, Han X, Frieden C, Dickson DW. Ross OA and Bu G. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021;13:eabc9375.","journal-title":"Sci Transl Med"},{"key":"524_CR301","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Keene CD, Kamboh MI, Kofler JK, Duque L, Gilbert JR, Gwirtsman HE, Buxbaum JD, Dickson DW, Frosch MP, Ghetti BF, Lunetta KL, Wang LS, Hyman BT, Kukull WA, Foroud T, Haines JL, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Farrer LA, Schellenberg GD, Beecham GW, Montine TJ, Jun GR. Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020;11:667.","journal-title":"Nat Commun"},{"key":"524_CR302","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2017.11.027","volume":"664","author":"\u00c1 Feh\u00e9r","year":"2018","unstructured":"Feh\u00e9r \u00c1, Giricz Z, Juh\u00e1sz A, P\u00e1k\u00e1ski M, Janka Z, K\u00e1lm\u00e1n J. ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer\u2019s disease. Neurosci Lett. 2018;664:79\u201383.","journal-title":"Neurosci Lett"},{"key":"524_CR303","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020;23:1183\u201393.","journal-title":"Nat Neurosci"},{"key":"524_CR304","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/ADR-210283","volume":"5","author":"S Fereshetian","year":"2021","unstructured":"Fereshetian S, Agranat JS, Siegel N, Ness S, Stein TD, Subramanian ML. Protein and Imaging Biomarkers in the Eye for Early Detection of Alzheimer\u2019s Disease. J Alzheimers Dis Rep. 2021;5:375\u201387.","journal-title":"J Alzheimers Dis Rep"},{"key":"524_CR305","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1172\/JCI77398","volume":"127","author":"I Livne-Bar","year":"2017","unstructured":"Livne-Bar I, Wei J, Liu HH, Alqawlaq S, Won GJ, Tuccitto A, Gronert K, Flanagan JG, Sivak JM. Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury. J Clin Invest. 2017;127:4403\u201314.","journal-title":"J Clin Invest"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00524-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-022-00524-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00524-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T18:18:52Z","timestamp":1726856332000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-022-00524-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":305,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["524"],"URL":"https:\/\/doi.org\/10.1186\/s13024-022-00524-0","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}